MedPath

Davos@home: eHealth support of patients with severe asthma after AACT (Alpine Altitude Climate Therapy)

Completed
Conditions
severe asthma
10006436
Registration Number
NL-OMON54107
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
126
Inclusion Criteria

Adult patients with severe asthma who are referred to AACT in the Dutch Asthma
Center Davos. To be eligible for AACT, patients need to have uncontrolled
asthma despite using high doses of inhaled corticosteroids combined with
long-acting bronchodilators for more than 1 year. They have also experienced at
least two severe exacerbations requiring a course of oral corticosteroids
during the past year, or received maintenance oral corticosteroid therapy.
There are no additional eligibility criteria specifically for this study.

Exclusion Criteria

Not in possession of a smartphone.
Not being able to read or write.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome is the time to first exacerbation. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes are total exacerbation rate, asthma control, asthma-related<br /><br>quality of life, fatigue, depression, health care utilisation, work<br /><br>productivity and activity impairment, and technology acceptance. </p><br>
© Copyright 2025. All Rights Reserved by MedPath